What You Should Know: - Anumana, an AI-driven health technology company and portfolio company of nference, today announced a multi-year agreement with Pfizer for Anumana to develop an investigational artificial intelligence electrocardiogram algorithm (AI-ECG) designed to enable the early identification of patients who may be at risk of cardiac amyloidosis. - Anumana will conduct a clinical validation trial and pursue De Novo classification for the algorithm as a
Read More
nference
Research Shows Power of Anumana AI-ECG Algorithms to Detect Heart Conditions
What You Should Know: - The research is mounting to show that Anumana’s AI-ECG algorithms could dramatically improve screening for cardiovascular disease (CVD), providing early warnings of disease from just a standard electrocardiogram (ECG). Yesterday, a study was published in Nature Medicine that shows an Anumana AI algorithm applied to Apple Watch ECG recordings successfully identified a weak heart pump in patients. - This follows other recent research findings, published in The
Read More
How AI is Enabling Next-Generation Insights from Biomedical Data
COVID-19 caught the world off-guard, sending governments, populations, and the entire healthcare community — physicians, nurses, scientists, pharmaceutical companies, and medical device manufacturers included — scrambling to discover and deliver rapid solutions as millions of lives hanging in the balance. The heroic efforts of everyone involved have at last brought the end into view; now, as we begin to emerge from the pandemic and are able to assess its long-term impact, one important
Read More
nference Raises $11M to Synthesize the World’s Biomedical Knowledge
nference, a Cambridge, MA-based company on a mission to synthesize the exponentially growing biomedical knowledge has raised $11 million in Series A funding led by Matrix Partners. The round also included participation from existing investor Matrix Capital Management. The company plans to utilize the funding to develop the company’s AI and R&D platforms, expand scientific operations in Cambridge MA and establish nference Labs in Bangalore, India.Founded by Murali Aravamudan and Venky
Read More
